{"id":13566,"date":"2019-03-14T15:17:07","date_gmt":"2019-03-14T14:17:07","guid":{"rendered":"https:\/\/www.satt.fr\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/"},"modified":"2019-03-18T10:40:37","modified_gmt":"2019-03-18T09:40:37","slug":"inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/","title":{"rendered":"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion"},"content":{"rendered":"

<\/p>\n

\"\"InBrain Pharma est une soci\u00e9t\u00e9 de biotechnologie d\u00e9veloppant des solutions innovantes pour lutter contre les maladies neurod\u00e9g\u00e9n\u00e9ratives bas\u00e9es sur la Brain Infusion, consistant en l\u2019administration contr\u00f4l\u00e9e d\u2019une substance au niveau du syst\u00e8me nerveux central. Cr\u00e9\u00e9e en 2018 \u00e0 partir de travaux de recherche men\u00e9s par le Pr. David DEVOS, la start-up annonce un financement de 1 million d\u2019euros en amor\u00e7age, boucl\u00e9 lors d\u2019un tour de table aupr\u00e8s de Finovam, Nord France Amor\u00e7age et un r\u00e9seau de Business Angels. Ce financement vise notamment \u00e0 engager des essais cliniques chez l\u2019Homme pour sa nouvelle solution th\u00e9rapeutique \u00e0 destination des patients atteints par la maladie de Parkinson<\/p>\n

La maladie de Parkinson touche actuellement 200 000 personnes en France, dont 22 000 cas en r\u00e9gion Hauts-de-France. Face aux manques de solutions \u00e0 proposer aux patients et fort de r\u00e9sultats de recherche prometteurs, l\u2019\u00e9quipe d\u2019InBrain Pharma s\u2019engage pour offrir de nouveaux traitements bas\u00e9s sur la Brain Infusion, consistant en l\u2019administration contr\u00f4l\u00e9e d\u2019une substance au niveau du syst\u00e8me nerveux central.<\/p>\n

\u00c0 l\u2019instar du concept d\u2019administration en continue d\u2019insuline chez les patients diab\u00e9tiques, le Pr David DEVOS a l\u2019id\u00e9e de d\u00e9velopper l\u2019administration de la dopamine en condition ana\u00e9robie et en intrac\u00e9r\u00e9brale aux patients atteints de la maladie de Parkinson au stade de complications du traitement oral, soit apr\u00e8s 5 \u00e0 7 ans d\u2019\u00e9volution.De nombreuses marques d\u2019int\u00e9r\u00eats recens\u00e9es aupr\u00e8s d\u2019acteurs industriels pharmaceutiques viennent confirmer le potentiel de la technologie. En parall\u00e8le, les succ\u00e8s et distinctions se multiplient et renforcent la reconnaissance scientifique du projet.<\/p>\n

En 2017, InBrain Pharma est d\u00e9sign\u00e9e laur\u00e9ate de l\u2019appel \u00e0 manifestation d\u2019int\u00e9r\u00eat de la Fondation de l\u2019Universit\u00e9 de Lille qui lui permet d\u2019obtenir un financement de 200 000 euros. En 2018, l\u2019entreprise InBrain Pharma est cr\u00e9\u00e9e pour exploiter la technologie gr\u00e2ce \u00e0 une licence sign\u00e9e avec la SATT Nord. Cette m\u00eame ann\u00e9e la start-up figure \u00e9galement parmi les laur\u00e9ats du concours de l\u2019innovation i-Lab. Elle obtient par ailleurs un financement via le Plan d\u2019Investissement d\u2019Avenir op\u00e9r\u00e9 par Bpifrance et la r\u00e9gion Hauts-de-France.
\nFin 2018, InBrain Pharma r\u00e9alise sa premi\u00e8re lev\u00e9e de fonds pour un montant de plus d\u20191 million d\u2019euros aupr\u00e8s de Finovam Gestion, de Nord France Amor\u00e7age et de Business Angels.<\/p>\n

\"\"<\/strong><\/p>\n

\u00ab\u00a0Le programme de maturation de la SATT Nord dont a b\u00e9n\u00e9fici\u00e9 InBrain Pharma a permis dans un premier temps de consolider et de prot\u00e9ger les r\u00e9sultats des travaux de recherche sur lesquels la start-up s\u2019appuie aujourd\u2019hui. Agissant comme un v\u00e9ritable facilitateur pour les porteurs de projets issus de la recherche, la SATT Nord poursuit son accompagnement \u00e0 destination d\u2019InBrain Pharma en lui permettant d\u2019acc\u00e9der aux conseils et expertises de nos \u00e9quipes \u00bb\u00a0<\/strong><\/p>\n

Fabrice LEFEBVRE, Pr\u00e9sident de la SATT Nord<\/strong><\/p>\n

 <\/p>\n

T\u00e9l\u00e9chargez le dossier de presse<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":13574,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567],"tags":[],"class_list":["post-13566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"acf":[],"yoast_head":"\nInBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caroline BRILLANT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/\"},\"author\":{\"name\":\"Caroline BRILLANT\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/cfc3546ad932d078cb047ce83a0742ea\"},\"headline\":\"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion\",\"datePublished\":\"2019-03-14T14:17:07+00:00\",\"dateModified\":\"2019-03-18T09:40:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/\"},\"wordCount\":539,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/IBP.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/\",\"name\":\"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/IBP.png\",\"datePublished\":\"2019-03-14T14:17:07+00:00\",\"dateModified\":\"2019-03-18T09:40:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/cfc3546ad932d078cb047ce83a0742ea\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/IBP.png\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2019\\\/03\\\/IBP.png\",\"width\":1295,\"height\":722},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/cfc3546ad932d078cb047ce83a0742ea\",\"name\":\"Caroline BRILLANT\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/caroline-admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/","twitter_misc":{"Written by":"Caroline BRILLANT","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/"},"author":{"name":"Caroline BRILLANT","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/cfc3546ad932d078cb047ce83a0742ea"},"headline":"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion","datePublished":"2019-03-14T14:17:07+00:00","dateModified":"2019-03-18T09:40:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/"},"wordCount":539,"image":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/03\/IBP.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/","url":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/","name":"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/03\/IBP.png","datePublished":"2019-03-14T14:17:07+00:00","dateModified":"2019-03-18T09:40:37+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/cfc3546ad932d078cb047ce83a0742ea"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/03\/IBP.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2019\/03\/IBP.png","width":1295,"height":722},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/inbrain-pharma-soutenue-par-la-satt-nord-leve-1-million-deuros-pour-accelerer-le-developpement-de-sa-technologie-de-brain-infusion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"InBrain Pharma soutenue par la SATT Nord l\u00e8ve 1 million d\u2019euros pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de brain infusion"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d'Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/cfc3546ad932d078cb047ce83a0742ea","name":"Caroline BRILLANT","url":"https:\/\/www.satt.fr\/en\/author\/caroline-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=13566"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13566\/revisions"}],"predecessor-version":[{"id":13571,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/13566\/revisions\/13571"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/13574"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=13566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=13566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=13566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}